August 7, 2007 - FDA Clearance for AED Pro with See-Thru CPR INVESTOR CONTACT: A. Ernest WhitonChief Financial OfficerZOLL Medical Corporation+1 (978) 421-9655 MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) email@example.com ZOLL Receives Clearance to Market AED Pro with See-Thru CPR Technology Helps Minimize Interruptions in CPR August 7, 2007—CHELMSFORD, MASS.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL AED Pro® with See-Thru CPR™ technology. ZOLL’s patented See-Thru CPR helps minimize interruptions in CPR—one of the key recommendations of the American Heart Association’s (AHA) Guidelines for Advanced Cardiac Life Support. See-Thru CPR reduces interruptions by allowing clinicians to see organized electrical activity during CPR compressions by filtering out compression artifact (“noise”). This lets rescuers see a patient’s underlying cardiac rhythm during resuscitation efforts and eliminates the need to stop compressions to see if defibrillation was successful. The AHA notes that a primary source of interruption of CPR is stopping to determine underlying ECG rhythm. “This exclusive ZOLL technology allows the professional rescuer to analyze a patient’s heart rhythm while continuous CPR is in progress and monitor the heart rhythm to determine the appropriate time to analyze or stop CPR to check the ECG,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “It contributes to helping rescuers and clinicians save more lives.” Manual Mode Only See-Thru CPR will only be activated when the AED Pro is in Manual Mode. The feature will not be enabled when the AED Pro is operating in semi-automatic mode. See-Thru CPR will automatically “turn on” when the rescuer switches the unit from semi-automatic to manual, which is accomplished by depressing two soft keys. AED Pro: Advanced Capabilities, Rugged Construction The AED Pro is the first defibrillator designed for professional responders with instantaneous feedback on CPR chest compressions. Its unique real-time feedback, Real CPR Help™, includes a metronome set at the AHA-recommended 100 beats per minute and a screen display, which helps rescuers achieve the optimum rate and depth of compression levels through audible and/or visual prompts. All CPR data can be recorded and reviewed using RescueNet™ Code Review software. It also features a high-resolution ECG display, Lead II monitoring, and unrivaled battery compatibility. Its rugged construction and exceptional durability support the needs of both Basic Life Support and Advanced Life Support professionals in hospitals and emergency services. Sudden Cardiac Arrest: World’s Leading Cause of Unexpected Death Sudden cardiac arrest (SCA) is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. This lack of blood flow can result in the loss of blood pressure, pulse, and consciousness. SCA is the leading cause of unexpected death in the world and strikes without warning. In the U.S. alone, there are more than 325,000 deaths each year from cardiac arrest. Currently, only about 6 percent of victims survive. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on May 11, 2007. ©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. RescueNet and See-Thru CPR are trademarks of ZOLL Medical Corporation. AED Pro, Real CPR Help, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.